Prevention of postoperative recurrence of Crohn's disease

Journal of Crohn's and Colitis

Volumn 6, Issue 6, 2012, Pages 637-646

  Van Loo, E S ^a   Dijkstra, G ^a   Ploeg, R J ^a   Nieuwenhuijs, V B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Crohn; Postoperative; Recurrence; Surgery

Indexed keywords

AZATHIOPRINE; BUDESONIDE; INFLIXIMAB; INTERLEUKIN 10; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NITROIMIDAZOLE; ORNIDAZOLE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT;

CROHN DISEASE; DRUG EFFICACY; DRUG SCREENING; END TO END ANASTOMOSIS; ENDOSCOPY; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; LAPAROSCOPIC SURGERY; META ANALYSIS (TOPIC); NONHUMAN; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE RECURRENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE;

6-MERCAPTOPURINE; ANASTOMOSIS, SURGICAL; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTESTINE, SMALL; LAPAROSCOPY; MESALAMINE; NITROIMIDAZOLES; PROBIOTICS; RECURRENCE; TREATMENT OUTCOME;

EID: 84862168533     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.12.006     Document Type: Review

References (51)

1. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6):1504-1517.
2. Stange E.F., Travis S.P., Vermeire S., Beglinger C., Kupcinkas L., Geboes K., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006, 55(Suppl 1):i1-i15.
3. Stefanelli T., Malesci A., Repici A., Vetrano S., Danese S. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets. Curr Drug Targets 2008, 9(5):413-418.
4. Carter M.J., Lobo A.J., Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53(Suppl 5):V1-V16.
5. Freeman H.J. Long-term natural history of Crohn's disease. World J Gastroenterol 2009, 15(11):1315-1318.
6. Travis S.P., Stange E.F., Lemann M., Oresland T., Chowers Y., Forbes A., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006, 55(Suppl 1):i16-i35.
7. Delaney C.P., Kiran R.P., Senagore A.J., O'Brien-Ermlich B., Church J., Hull T.L., et al. Quality of life improves within 30days of surgery for Crohn's disease. J Am Coll Surg 2003, 196(5):714-721.
8. Ng S.C., Kamm M.A. Management of postoperative Crohn's disease. Am J Gastroenterol 2008, 103(4):1029-1035.
9. Regueiro M., Schraut W., Baidoo L., Kip K.E., Sepulveda A.R., Pesci M., et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009, 136(2):441-450.
10. Unkart J.T., Anderson L., Li E., Miller C., Yan Y., Gu C.C., et al. Risk factors for surgical recurrence after ileocolic resection of Crohn's disease. Dis Colon Rectum 2008, 51(8):1211-1216.
11. Simillis C., Yamamoto T., Reese G.E., Umegae S., Matsumoto K., Darzi A.W., et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease. Am J Gastroenterol 2008, 103(1):196-205.
12. Nos P., Domenech E. Postoperative Crohn's disease recurrence: a practical approach. World J Gastroenterol 2008, 14(36):5540-5548.
13. Caprilli R., Gassull M.A., Escher J.C., Moser G., Munkholm P., Forbes A., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006, 55(Suppl 1):i36-i58.
14. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005, 11(26):3971-3979.
15. Froehlich F., Juillerat P., Pittet V., Felley C., Mottet C., Vader J.P., et al. Maintenance of surgically induced remission of Crohn's disease. Digestion 2007, 76(2):130-135.
16. Domenech E., Manosa M., Bernal I., Garcia-Planella E., Cabre E., Pinol M., et al. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008, 14(4):508-513.
17. Pascua M., Su C., Lewis J.D., Brensinger C., Lichtenstein G.R. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease. Aliment Pharmacol Ther 2008, 28(5):545-556.
18. Caprilli R., Corrao G., Taddei G., Tonelli F., Torchio P., Viscido A. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum 1996, 39(3):335-341.
19. Cottone M., Orlando A., Viscido A., Calabrese E., Camma C., Casa A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003, 17(Suppl 2):38-42.
20. Yamamoto T., Keighley M.R. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000, 87(4):398-404.
21. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99(4):956-963.
22. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Fixed- Effect Versus Random-Effects Models. In: Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, Introduction to meta-analysis, John Wiley & Sons, Ltd. 2009;(10-13):59-86.
23. Cochrane handbook for systematic reviews of interventions version 5.1.0 2011, [updated March 2011]. J.P.T. Higgins, S. Green (Eds.).
24. Caprilli R., Andreoli A., Capurso L., Corrao G., D'Albasio G., Gioieni A., et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994, 8(1):35-43.
25. Brignola C., Cottone M., Pera A., Ardizzone S., Scribano M.L., De F R., et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995, 108(2):345-349.
26. Florent C., Cortot A., Quandale P., Sahmound T., Modigliani R., Sarfaty E., et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996, 8(3):229-233.
27. Lochs H., Mayer M., Fleig W.E., Mortensen P.B., Bauer P., Genser D., et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000, 118(2):264-273.
28. Hanauer S.B., Korelitz B.I., Rutgeerts P., Peppercorn M.A., Thisted R.A., Cohen R.D., et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004, 127(3):723-729.
29. McLeod R.S., Wolff B.G., Steinhart A.H., Carryer P.W., O'Rourke K., Andrews D.F., et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995, 109(2):404-413.
30. Caprilli R., Cottone M., Tonelli F., Sturniolo G., Castiglione F., Annese V., et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003, 17(4):517-523.
31. Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995, 108(6):1617-1621.
32. Rutgeerts P., Van A.G., Vermeire S., D'Haens G., Baert F., Noman M., et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005, 128(4):856-861.
33. Ardizzone S., Maconi G., Sampietro G.M., Russo A., Radice E., Colombo E., et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004, 127(3):730-740.
34. D'Haens G.R., Vermeire S., Van A.G., Noman M., Aerden I., Van O.G., et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008, 135(4):1123-1129.
35. Reinisch W., Angelberger S., Petritsch W., Shonova O., Lukas M., Bar-Meir S., et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 2010, 59(6):752-759.
36. Ewe K., Bottger T., Buhr H.J., Ecker K.W., Otto H.F. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999, 11(3):277-282.
37. Hellers G., Cortot A., Jewell D., Leijonmarck C.E., Lofberg R., Malchow H., et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999, 116(2):294-300.
38. Chermesh I., Tamir A., Reshef R., Chowers Y., Suissa A., Katz D., et al. Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci 2007, 52(2):385-389.
39. Prantera C., Scribano M.L., Falasco G., Andreoli A., Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002, 51(3):405-409.
40. Marteau P., Lemann M., Seksik P., Laharie D., Colombel J.F., Bouhnik Y., et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55(6):842-847.
41. Van G.A., Dewit O., Louis E., de H G., Baert F., Fontaine F., et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. Inflamm Bowel Dis 2007, 13(2):135-142.
42. Colombel J.F., Rutgeerts P., Malchow H., Jacyna M., Nielsen O.H., Rask-Madsen J., et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001, 49(1):42-46.
43. Fazio V.W., Marchetti F., Church M., Goldblum J.R., Lavery C., Hull T.L., et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 1996, 224(4):563-571.
44. Cameron J.L., Hamilton S.R., Coleman J., Sitzmann J.V., Bayless T.M. Patterns of ileal recurrence in Crohn's disease. A prospective randomized study. Ann Surg 1992, 215(5):546-551.
45. Ikeuchi H., Kusunoki M., Yamamura T. Long-term results of stapled and hand-sewn anastomoses in patients with Crohn's disease. Dig Surg 2000, 17(5):493-496.
46. McLeod R.S., Wolff B.G., Ross S., Parkes R., McKenzie M. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009, 52(5):919-927.
47. Stocchi L., Milsom J.W., Fazio V.W. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. Surgery 2008, 144(4):622-627.
48. http://clinicaltrials.gov/ct2/show/NCT01190839.
49. (Accessed 2004). http://www.cebm.net.
50. Meakins J.L. Innovation in surgery: the rules of evidence. Am J Surg 2002, 183(4):399-405.
51. Dignass A., Van A.G., Lindsay J.O., Lemann M., Soderholm J., Colombel J.F., et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010, 4(1):28-62.